Hormone Therapy and the BRCA1 Mutation

According to the results of a recent study published in the Journal of the National Cancer Institute, hormone therapy for postmenopausal women with a BRCA1 mutation does not appear to increase the risk of breast cancer.¹

Inherited mutations in two genes—BRCA1 and BRCA2—have been found to greatly increase the lifetime risk of developing breast and ovarian cancer. Read more

Oncotype DX® Accurately Determines HER2 Status in Breast Cancer

Oncotype DX® appears to determine HER2 status as accurately as standard laboratory testing methods. By the end of 2008, Genomic Health intends to provide HER2 status with results from all Oncotype DX testing. These results were recently presented at the 2008 American Society of Clinical Oncology (ASCO) Breast Meeting. Read more

Hope in Bloom

Roberta Hershon and her friend Beverly Eisenberg spent many wonderful hours together immersed in their Massachusetts gardens—planning, visiting nurseries, and working together in the dirt. When Beverly was diagnosed with breast cancer in 2004, her close circle of friends made sure that her garden was cared for, and, when she was unable to enjoy the outdoors, they ensured that she was still surrounded by the flowers and the green growing things that brought her so much joy and peace. Read more

Do Fruits and Vegetables Really Reduce Breast Cancer Risk?

Women who have been diagnosed with breast cancer often pay extra attention to their diet as a way to prevent recurrence of their cancer. Healthcare professionals and researchers alike have long suspected a correlation between healthful eating patterns and reduced risk of chronic diseases such as certain forms of cancer and heart disease. Read more